Reading Your Grant Notice: Lessons from Real SEC Filings

Many executives treat their grant paperwork as something to sign rather than something to read. The headline number from the offer or the annual grant conversation is easy to hold onto. The documents that follow seem dense with defined terms and references to a plan they've never seen and are therefore easy to set aside.

Most of what you need to read them is already covered on Payprweight. How Stock Options Work explains strike price, vesting, and expiration. How ISOs and NQSOs Differ explains the label at the top of most option grants. The glossary covers the documents themselves: the grant notice, the award agreement, the plan document behind them, and the vesting commencement date that anchors your schedule. This module shows you how to put all of it to work on real documents.

Public companies have to file many executive compensation agreements with the SEC, so signed grant notices for actual executives are available to anyone. We walk through four of them. None is unusual. Together, they show how much these documents can vary from company to company, and what to look for in your own.

Most option grants arrive as a set:

• The grant notice: a short summary, usually one page, listing the specifics of your grant. It's usually the page you sign or accept.
• The award agreement: the standard language the company uses for grants like yours. The grant notice is often its first page.
• The plan document: the company's rules for every award it makes, which the award agreement incorporates by reference.

You may also receive an award letter, which might be the award agreement itself or simply a cover letter announcing the grant.

One note before the examples. Three of the four are inducement grants: awards a company makes to bring a new executive on board. These inducement awards are granted outside the company's shareholder-approved equity plan under a Nasdaq listing rule that permits this for new hires. Each states that it will be governed as if it had been issued under the plan.

The baseline

Carlsmed's grant notice for a newly hired executive, signed September 28, 2026, follows a standard layout.

Carlsmed Inducement Stock Option Grant Notice (key fields)

Field labels and values are exactly as they appear on the notice; the vesting schedule text is condensed.

A few things are worth noticing:

• The option type is stated plainly. These are non-qualified stock options (NQSOs). "Nonstatutory" is another name for the same thing.
• The vesting commencement date matches the grant date, so the vesting clock starts the day the grant is made. The schedule is a one-year cliff vesting period followed by quarterly graded vesting. The 25% at the cliff and the twelve installments of 6.25% add up to 100%.
• The total exercise price is simple arithmetic: 180,137 shares × $14.18 = $2,554,342.66, rounded on the notice. The notice calls the $14.18 the exercise price, a synonym for the strike price. The total exercise price is what it would cost you to exercise the entire grant. Checking the math on your own notice takes a minute.
• The expiration date is the day before the tenth anniversary of the grant, not the anniversary itself. Read the date on your notice rather than assuming.
• Acceptance can be a click. The notice reads: "By your signature below or by electronic acceptance or authentication in a form authorized by the Company, you understand and agree that." Accepting on an equity platform carries the same weight as signing.

Same label, different meaning

Cerecor's notice for a newly hired executive uses one of the same labels as Carlsmed's, but with a different meaning.

• Award Date: March 1, 2021
• Vesting Commencement Date: "March 1, 2022 (with vesting schedule set forth below)"
• Vesting: "Twenty-Five (25%) of the Option Shares will vest on March 1, 2022," with the rest vesting in equal monthly installments over the following three years.

In practice, this grant vests much like Carlsmed's: a quarter of it after one year, and the rest in installments over the next three. The difference is the label "vesting commencement date." At Carlsmed, the vesting commencement date is when the clock starts. At Cerecor, it's the date of the first vest, a year after the grant.

Neither usage is technically wrong. The point is that the label alone may not tell you what a date means. Here, the vesting schedule does. Read the full schedule and, if necessary, work out the actual dates yourself.

Different labels and an uncommon schedule

Conformis's agreement for a newly hired executive covers 450,000 shares at a $0.61 strike price, granted March 14, 2022. It uses a third set of labels for the same dates:

The Same Dates, Three Sets of Labels

*Cerecor uses the label "Vesting Commencement Date" for its first vesting date, March 1, 2022, a year after the grant. Cerecor's vesting is measured from the award date.

At Conformis, the grant date and vesting start date are the same day, and the final exercise date is March 14, 2032.

The vesting schedule in this Conformis grant stands out:

Conformis Vesting Schedule

Graded vesting doesn't have to mean equal installments, and it doesn't have to run four years. This schedule runs eight years and puts most of the value in the middle. Don't assume your schedule follows a familiar pattern; read every row.

The agreement also contains this sentence: "This option satisfies in full all commitments that the Company has to the Participant with respect to the issuance of stock, stock options or other equity securities." In plain terms, accepting this grant means acknowledging that it covers everything the company owes the executive in equity. Clauses like this exist to settle, in writing, what was promised. If an offer letter or an earlier conversation promised more, such as a second grant after the first year, accepting language like this could make that promise harder to rely on. That's why it's worth comparing your grant documents against everything you were told about the grant, especially anything in writing, before you accept them. If something you were promised is missing or different, raise it before you sign.

One label, two types

UTG's standard grant notice, filed with its 2025 Stock Option Plan, is a blank template rather than a signed grant. We've included this example for one important reason. The type field reads "[Incentive Stock Option] OR [Nonstatutory Stock Option]." Later in the notice, the second bullet point explains the $100,000 annual limit on incentive stock options (ISOs), ending: "Any excess over $100,000 is a Nonstatutory Stock Option."

In other words, a grant marked as ISOs can still be partly NQSOs. How ISOs and NQSOs Differ explains the limit behind this. A notice like UTG's won't necessarily tell you how many of your shares fall on each side of it, so ask the company or check your equity account to find out which shares are which.

What to check on your own documents

1. The option type, and any sentence elsewhere that qualifies it.

2. Every date, and what each one means: the grant date, when vesting starts, the first and last vesting dates, and the expiration date. Labels may vary; the vesting schedule is what counts.

3. The arithmetic: shares × strike price should equal the total exercise price, and the vesting percentages should add up to 100%.

4. The grant documents against everything you were told, in conversation and especially in writing, before you accept.

5. The notice against the agreement and the plan. If they happen to disagree, ask the company to confirm in writing which is correct.

6. A copy of everything you accepted. Equity platforms change, and you may need these documents years from now.

Grant notices largely look standardized, but labels, layouts, and even the meaning of a term may change from company to company. None of the four examples here is unusual. Reading your own documents carefully, with the vesting schedule rather than the labels as your guide, is how you confirm that the grant you accepted is the grant you were promised. Payprweight's education section answers many of the questions that come up as you work through these documents.

Every document discussed and linked in this module is a public filing, available to anyone through the SEC's EDGAR database. Payprweight did not use any information submitted to the platform nor did it break confidentiality in utilizing public filings.